Zimmer Biomet Holdings, Inc.
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, u…
What to know about ZBH
Zimmer Biomet Holdings, Inc. is a large Healthcare company with a mixed financial profile. It scores well on valuation and risk, but size is worth keeping an eye on.
Should you consider ZBH?
Based on 31 financial metrics and sector comparison. Not financial advice.
-
Zimmer Biomet Holdings, Inc. is a large-cap Healthcare company with a mixed overall financial profile — it is in the lower half of its Healthcare peers (42 of 59).
-
Profitability is roughly average for the S&P 500 — not a standout in either direction.
-
Valuation looks attractive — the stock is priced reasonably relative to its earnings and sales compared to most peers. You're not overpaying for the business.
-
The company is growing at a reasonable pace — not the fastest, but consistently moving in the right direction.
-
There is a small dividend (0.01%), but income-focused investors will likely find better yields elsewhere in the market.
-
Risk is relatively low — the stock tends to be less volatile than the broader market, which typically means a smoother ride during uncertain periods.
-
Analyst sentiment is cautious and short interest is relatively elevated — meaning some professional investors are actively betting the price will fall. Worth understanding why.
-
This is a mixed picture — real strengths in some areas, but areas that need watching too. Do your homework on the sector before deciding.
At a glance
How it scores
We look at 31 different financial metrics and group them into categories. Here's how ZBH compares to the other S&P 500 stocks.
Dive deeper — all 31 metrics 9 categories · valuation, growth, health, dividends & more Show all Hide
Valuation
Is the stock cheap or expensive relative to its earnings, sales, and assets? Lower multiples often mean better value.
| Metric | Value | vs S&P 500 |
|---|---|---|
| P/E Ratio (Trailing) | 22.79 | Above avg |
| Forward P/E | 9.79 | Top 25% |
| PEG Ratio | 0.63 | Top 25% |
| Price to Sales | 2.02 | Above avg |
| Price to Book | 1.34 | Top 25% |
| EV/EBITDA | 9.45 | Top 25% |
| Earnings Yield | 4.39% | Above avg |
Profitability
How efficiently does the company turn revenue into profit? Higher margins mean more money kept from each dollar earned.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Gross Margin | 70.18% | Top 25% |
| Operating Margin | 19.69% | Above avg |
| Net Profit Margin | 9.05% | Average |
| Return on Equity | 6.07% | Below avg |
| Return on Invested Capital | 4.10% | Average |
Growth
How fast is the business expanding? Strong growth in revenue and earnings signals increasing market demand.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Revenue Growth (YoY) | 9.30% | Above avg |
| Revenue Growth (3Y CAGR) | 5.85% | Above avg |
| EPS Growth (YoY) | 34.10% | Above avg |
| Free Cash Flow Growth | 24.30% | Above avg |
Health
Can the company cover its debts and obligations? A healthy balance sheet reduces the risk of financial trouble.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Current Ratio | 1.73 | Above avg |
| Debt to Equity | 0.60 | Above avg |
| Interest Coverage | 3.84 | Average |
| Altman Z-Score | 2.34 | Average |
Dividends
Does the company pay shareholders, and is that payment growing and sustainable?
| Metric | Value | vs S&P 500 |
|---|---|---|
| Dividend Yield | 1.07% | Below avg |
| Payout Ratio | 24.87% | Above avg |
| Dividend Growth (5Y) | -23.76% | Below avg |
Cash Flow
Is real cash flowing into the business — not just accounting profits? Strong cash flow funds growth and dividends.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Free Cash Flow Yield | 8.04% | Top 25% |
| OCF to Sales | 19.90% | Average |
Risk
How volatile is the stock compared to the broader market? Lower beta and volatility mean a smoother ride.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Beta (1-Year) | 0.47 | Top 25% |
| Volatility (30-Day) | 26.22% | Above avg |
Sentiment
What do analysts and short-sellers think? High analyst ratings and low short interest signal broad confidence.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Short % of Float | 5.92% | Average |
| Avg. Analyst Rating | 2.54 | Below avg |
| Target Upside % | 12.20% | Average |
Size
How large is the company by market value? Size affects stability, growth potential, and index inclusion.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Market Capitalization | 17.02B | Below avg |
How does ZBH compare to…?
Pick another stock and see them side by side in seconds.
You might also look at
Companies in a similar position to ZBH — based on their financial profile.